Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

New Procedures for Incoming Passengers starting 27/9/2022

 


Procedures for All Incoming Passengers to Lebanon
 
Privacy Policy
The data on this platform is processed in line with the laws in force in the Lebanese Republic, especially the Law of Electronic Transactions and Personal Data No. 81 of 10/10/2018.

The data is currently hosted on a secure cloud that is ISO27001, NIST 800-53 and GDPR compliant and all security requirements are in place to secure the infrastructure. The data and application hosting will be migrated to a secure national datacenter at a later stage.

Work is done with a company specialized in information protection and security and all security requirements on this platform and all security requirements are based on: OWASP Top 10 web applications security risks, OWASP Top 10 API security and OWASP ASVS best practices were taken into consideration during the development phase. Penetration tests are being conducted on the test environment in order to ensure that no vulnerabilities exist before the live implementation. Ongoing penetration tests and checks are being conducted on the live environment in order to ensure that both environments are secured.

We ensure to maintain the confidentiality of your information and provide physical, electronic and procedural safeguards to ensure the protection of the information we process and keep on a secure server. Your data is shared with the laboratory to input the result of the PCR test result done at the airport and the result is sent to your phone via an SMS.

The information you disclosed, such as your name, your father's name, first name, date of birth and place of residence, is encrypted and stored in a secure manner and cannot be accessed by the public, and you have the right to view, correct, modify or delete your data from the database.

We will use your personal information if you are infected with the Coronavirus and you were tested positive for COVID-19 or have been in contact with a positive case, to contact you and give you the necessary directions. Your data will be shared with the Ministry of Interior and Municipalities in order to take preventive measures such as isolation or to do a PCR test to limit the spread of the virus.

Storing this data aims to confront a global epidemic, to contribute to limiting the spread of the Covid-19 epidemic, and to preserve the public health in the Lebanese Republic.


The Privacy Policy
 
MOPH PASS Refund 
Refund Policy:
If you registered on the
https://pass.moph.gov.lb  platform and paid the cost of the PCR test via credit card or via the electronic document EMD and decided not to travel to Lebanon or postpone the travel, you can submit a request for a refund in writing to PASS@MOPH.GOV.LB  within a month of registering on the platform.
All refund requests will be reviewed and evaluated based on the payment status and arrival in Lebanon before a decision is made.
The Ministry reserves the right to refuse a refund based on the data registered in the platform.

MOPH PASS Refund Request
 
Memos and Decisions
 
 




    4
    ...
ATC Name B/G Ingredients Dosage Form Price
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 111,983,163 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
L01FA01 RUXIENCE BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 59,148,151 L.L
A10AD06 RYZODEG BioTech Insulin degludec - 70%, Insulin aspart - 30% 100IU/ml Injectable solution 7,058,661 L.L
C10AX13 REPATHA BioTech Evolocumab - 140mg/1ml Injectable solution 44,151,793 L.L
B03XA06 REBLOZYL BioTech Luspatarcept - 25mg 25mg Injectable powder for solution 125,960,784 L.L
B03XA06 REBLOZYL BioTech Luspatercept - 75mg 75mg Injectable powder for solution 377,881,318 L.L
L03AB07 RECIGEN 44 BioTech Interferon beta-1a - 44mcg/0.5ml 44mcg/0.5ml Injectable solution L.L
L03AB07 REBIF BioTech Interferon beta-1a - 44mcg/0.5ml 12MIU Injectable solution 79,337,698 L.L
L03AB07 RECIGEN 44 BioTech Interferon beta-1a - 44mcg/0.5ml 44mcg/0.5ml Injectable solution 15,147,973 L.L
L01FA01 RITUXIREL BioTech Rituximab - 100mg 100mg/10ml Injectable concentrated solution L.L
L01FA01 RITUXIREL BioTech Rituximab - 500mg 500mg/10ml Injectable concentrated solution L.L
L03AB07 REBIF BioTech Interferon beta-1a - 44mcg/0.5ml 12MIU Injectable solution L.L
C09BB07 RAMIPRIL/AMLODIPINE GENERICON G Ramipril - 2.5mg, Amlodipine - 5mg Capsule, hard 1,358,625 L.L
C09BB07 RAMIPRIL/AMLODIPINE GENERICON G Ramipril - 5mg, Amlodipine - 5mg Capsule, hard 1,358,625 L.L
B01AF01 RIBAVAN G Rivaroxaban - 20mg 20mg Tablet, film coated 1,343,843 L.L
C09BB07 RAMIPRIL/AMLODIPINE GENERICON G Ramipril - 10mg, Amlodipine - 5mg Capsule, hard 1,358,625 L.L
R06AX27 RINA 5 G Desloratadine - 5mg 0.5mg/ml Tablet, film coated 134,384 L.L
B01AF01 RIXALTA 20 G Rivaroxaban - 20mg 20mg Tablet, film coated 1,164,664 L.L
C09BB07 RAMIPRIL/AMLODIPINE GENERICON G Ramipril - 10mg, Amlodipine - 10mg Capsule, hard 1,358,625 L.L
L03AX16 REVIXIL 20 G Plerixafor - 20mg/ml 20mg/ml Injectable solution 248,280,900 L.L
B01AF01 RIBAVAN G Rivaroxaban - 10mg 10mg Tablet, film coated 959,888 L.L
B01AF01 RIXALTA 10 G Rivaroxaban - 10mg 10mg Tablet, film coated 671,921 L.L
G04BE08 RAVANA G Tadalafil - 20mg 20mg Tablet 500,421 L.L
R06AX27 RINA G Desloratadine - 0.5mg/ml 0.5mg/ml Syrup 159,917 L.L
C03BA11 RAWEL SR G Indapamide - 1.5mg 1.5mg Tablet, prolonged release 362,837 L.L
R06AX28 RUPATADINE BIOGARAN G Rupatadine - 10mg 10mg Tablet 341,336 L.L
M01AE51 RELI-FLU G Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg Tablet, film coated 139,504 L.L
G04BE08 RAVANA G Tadalafil - 5mg 5mg Tablet 1,501,264 L.L
J01DB05 ROXIL G Cefadroxil (monohydrate) - 250mg/5ml 250mg/5ml Powder for suspension 459,594 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025